Key result
Continued alpha-blocker therapy after transurethral resection of the prostate was associated with a lower risk of hip fracture requiring surgery compared to discontinuation.
Why the study?
Although alpha-blockers are commonly prescribed for lower urinary tract symptoms after TURP, their long-term safety regarding fracture risk remains controversial.
Does continued alpha-blocker treatment after TURP reduce the risk of hip fractures requiring surgery in male patients aged ≥50 years?
Cohort (n=6,853)
Does continued alpha-blocker treatment after TURP reduce the risk of hip fractures requiring surgery in male patients aged ≥50 years?
Continued alpha-blocker therapy after TURP is associated with a decreased risk of hip fractures requiring surgery in elderly men, particularly those with diabetes.
Answers are grounded in this paper and cite their sources.
Alpha-blocker continuation after TURP was associated with lower hip fracture risk; leaves open whether this warrants practice change pending RCTs.
Hip fractures significantly affect mortality and quality of life in the elderly population. Although alpha-blockers are commonly prescribed for lower urinary tract symptoms after transurethral resection of the prostate (TURP), their long-term safety regarding fracture risk remains controversial. This study aimed to investigate whether long-term alpha-blocker use after TURP affects the risk of hip fractures requiring surgery in elderly men. This study included 6853 male patients aged ≥50 years who underwent TURP between 2000 and 2018. The alpha-blocker group (n = 1371) included patients who continued alpha-blocker treatment after TURP, while the control group (n = 5482) included those who had discontinued the medication. The primary outcome was hip fracture requiring surgical intervention. During follow-up (3.80 ± 1.64 years), hip fracture occurred in 4.2% of the alpha-blocker group versus 5.6% of controls. After adjusting for baseline characteristics and competing risk analysis, alpha-blocker use was associated with a significantly lower risk of hip fracture (p = 0.005). Subgroup analysis revealed particularly strong protective effects in patients with diabetes. Long-term use of alpha-blockers after TURP was associated with reduced hip fracture risk, particularly in patients with diabetes. These findings suggest the safety of continued alpha-blocker therapy after TURP in these patients.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) conducted a cohort in Benign Prostate Hyperplasia (n=6,853). Alpha-blocker continuation vs. Alpha-blocker discontinuation was evaluated on Hip fracture requiring surgical intervention (p=0.005). Continued alpha-blocker therapy after transurethral resection of the prostate was associated with a lower risk of hip fracture requiring surgery compared to discontinuation.
Synapse has enriched 10 related papers. Consider them for comparative context: